| |
Total (N = 246)
|
English Version (n = 160)
|
Chinese Version (n = 86)
|
P-value
|
|---|
|
Demographic information
|
|
Age, mean (± SD)
|
53.4 (±10.0)
|
51.2 (± 10.3)
|
57.4 (±8.0)
|
< 0.001#
|
|
Gender, n (%)
| | | |
0.192
|
|
Female
|
230 (93.5)
|
152 (95.0)
|
78 (90.7)
| |
|
Male
|
16 (6.5)
|
8 (5.0)
|
8 (9.3)
| |
|
Race, n (%)
| | | |
< 0.001#
|
|
Chinese
|
198 (80.5)
|
114 (71.3)
|
84 (97.7)
| |
|
Non-Chinese
| | | | |
|
Malay
|
26 (10.6)
|
26 (16.3)
|
0 (0.0)
| |
|
Indians
|
12 (4.9)
|
12 (7.5)
|
0 (0.0)
| |
|
Others
|
10 (4.1)
|
8 (5.0)
|
2 (2.3)
| |
|
Marital Status, n (%)
| | | | |
|
Single
|
45 (18.3)
|
32 (20.0)
|
13 (15.1)
|
0.546
|
|
Married
|
181 (73.6)
|
116 (72.5)
|
65 (75.6)
| |
|
Divorced
|
17 (6.9)
|
11 (6.9)
|
6 (7.0)
| |
|
Widowed
|
3 (1.2)
|
1 (0.6)
|
2 (2.3)
| |
|
Education, n (%)
| | | |
< 0.001#
|
|
Low Education
|
42 (17.1)
|
6 (3.8)
|
36 (41.9)
| |
|
None
|
9 (3.7)
|
2 (1.3)
|
7 (8.1)
| |
|
Primary
|
33 (13.4)
|
4 (2.5)
|
29 (33.7)
| |
|
High Education
|
204 (82.9)
|
154 (96.3)
|
50 (58.1)
| |
|
Secondary
|
111 (45.1)
|
73 (45.6)
|
38 (44.2)
| |
|
Pre-University
|
45 (18.3)
|
37 (23.1)
|
8 (9.3)
| |
|
Graduate and Above
|
48 (19.5)
|
44 (27.5)
|
4 (4.7)
| |
|
Occupation, n (%)
| | | |
0.097
|
|
Employed
|
130 (52.8)
|
93 (58.1)
|
37 (43.0)
| |
|
Unemployed
|
90 (36.6)
|
53 (33.1)
|
37 (43.0)
| |
|
Student
|
1 (0.4)
|
1 (0.6)
|
0 (0.0)
| |
|
Retired
|
25 (10.2)
|
13 (8.1)
|
12 (14.0)
| |
|
Clinical Information
|
|
ECOG, n (%)
| | | |
0.030#
|
|
0
|
221 (89.8)
|
149 (93.1)
|
72 (83.7)
| |
|
1
|
15 (6.1)
|
6 (3.8)
|
9 (10.5)
| |
|
Missing
|
10 (4.1)
|
5 (3.1)
|
5 (5.8)
| |
|
Menopausal status, n (%)
| | | |
< 0.001#
|
|
Pre-menopausal
|
98 (39.8)
|
79 (49.4)
|
19 (22.1)
| |
|
Post-menopausal
|
129 (52.4)
|
71 (44.4)
|
58 (67.4)
| |
|
Not Applicable
|
16 (6.5)
|
8 (5.0)
|
8 (9.3)
| |
|
Missing
|
3 (1.2)
|
2 (1.3)
| | |
|
Cancer Diagnosis, n (%)
| | | |
0.427
|
|
Breast
|
225 (91.5)
|
148 (92.5)
|
77 (89.5)
| |
|
Lymphoma
|
21 (8.5)
|
12 (7.5)
|
9 (10.5)
| |
|
Cancer Stage, n (%)
| | | |
0.554
|
|
I
|
34 (13.8)
|
26 (16.3)
|
8 (9.3)
| |
|
II
|
134 (54.5)
|
87 (54.4)
|
47 (54.7)
| |
|
III
|
50 (20.3)
|
31 (19.4)
|
19 (22.1)
| |
|
IV
|
23 (9.3)
|
15 (9.4)
|
8 (9.3)
| |
|
Unknown
|
5 (2.0)
|
1 (0.6)
|
4 (4.7)
| |
|
Chemotherapy Regimen, n (%)
| | | |
0.819
|
|
Anthracycline containing
|
132 (53.7)
|
85 (53.1)
|
47 (54.7)
| |
|
Non-anthracycline containing
|
114 (46.3)
|
75 (46.9)
|
39 (45.3)
| |
- ECOG Eastern Cooperative Oncology Group, Pre-M pre-menopausal, Post-M post-menopausal
- #Denotes statistically significant difference (P < 0.05)
